Results 31 to 40 of about 109,330 (215)
Contains fulltext : 24337___.PDF (Publisher’s version ) (Open Access)
openaire +3 more sources
Background: Lupus nephritis is one of the most serious complications of systemic lupus erythematosus (SLE). Urinary neutrophil gelatinase-associated lipocalin (NGAL) is a non-invasive biomarker that may aid in diagnosing active lupus nephritis.
Anthony Chakma +4 more
doaj +1 more source
Background Systemic lupus erythematosus (SLE) is a complex systemic autoimmune disease characterized by development of autoantibodies and multiorgan involvement. Kidney involvement, termed lupus nephritis, has major impact on life expectancy.
Yi Tong V. Aw +14 more
doaj +1 more source
Lupus Nephritis in Children: Novel Perspectives
Childhood-onset systemic lupus erythematosus is an inflammatory and autoimmune condition characterized by heterogeneous multisystem involvement and a chronic course with unpredictable flares.
Marco Pennesi, Simone Benvenuto
doaj +1 more source
Lupus Nephritis: Current Perspectives and Moving Forward
Julia Lichtnekert, Hans-Joachim Anders, Maciej Lech Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, LMU München, München, GermanyCorrespondence: Maciej Lech, Medizinische Klinik und Poliklinik IV Klinikum
Lichtnekert J, Lech M, Anders HJ
core
Phenotyping renal leukocyte subsets by four-color flow cytometry: Characterization of chemokine receptor expression [PDF]
To investigate mechanisms of cell-mediated injury in renal inflammatory disease it is critical to determine the surface phenotype of infiltrating renal leukocyte subsets.
Anders, Hans-Joachim +5 more
core +1 more source
Background: Lupus nephritis (LN) is the assemblage of glomerular, tubulointerstitial and vascular changes. Despite the fact that glomerular changes are overemphasized in pathological classification and scoring system, but the existence of vascular damage
Madhumita Paul +5 more
doaj +1 more source
The treatment of lupus nephritis [PDF]
New and more conservative approaches in treatment are a major advance F or 30 years the US National Institutes of Health have dominated the treatment of lupus nephritis with controlled trials of monthly high dose intravenous pulse cyclophosphamide, now the standard treatment for nephritis and severe lupus.
David P, D'Cruz, Graham R V, Hughes
openaire +2 more sources
Objective Clinical response to mycophenolic acid (MPA) is highly heterogeneous; thus, therapeutic drug level monitoring (TDM) may help improve treatment efficacy. This systematic review and meta‐analysis examined therapeutic ranges for MPA levels associated with better outcomes and safety in patients with systemic lupus erythematosus (SLE ...
Zahraa Qamhieh +5 more
wiley +1 more source
Objective: To assess clinicopathological characteristics in adult patients with early and delayed lupus nephritis. Method: The comparative, cross-sectional study was conducted at the Department of Nephrology, Sindh Institute of Urology and ...
Anmol +3 more
doaj +1 more source

